Yongchang Qiu

Founder & Chief Executive Officer Lysoway Therapeutics

Seminars

Thursday 5th February 2026
Restoring the Autophagy–Lysosomal Pathway Through Endolysosomal Ion Channels To treat Age-Related Neurodegeneration
1:30 pm
Yongchang Qiu, Founder & CEO, Lysoway Therapeutics - 14th Alzheimers & Parkinsons Drug Development Summit